Inventors list |
Assignees list |
Classification tree browser |
Top 100 Inventors |
Top 100 Assignees |
Nora
Nora Alonso Casajus, Pamplona ES
| Patent application number | Description | Published |
|---|---|---|
| 20090288219 | Method of Production of Recombinant Sucrose Synthase, Use Thereof in the Manufacture of Kits for Determination of Sucrose, Production of Adpglucose and Production of Transgenic Plants Whose Leaves and Storage Organs Accumulate High Contents of Adpglucose and Starch - Method of production of recombinant sucrose synthase, use thereof in the manufacture of kits for determination of sucrose, production of ADPglucose and production of transgenic plants whose leaves and storage organs accumulate high contents of ADPglucose and starch | 11-19-2009 |
Nora Alonso Casajús, Pamplona ES
| Patent application number | Description | Published |
|---|---|---|
| 20110271401 | PROCEDURE FOR PRODUCING TRANSGENIC PLANTS PROVIDING HIGH STARCH CONTENT AND YIELD AND HIGH AMYLOSE/AMYLOPECTIN BALANCE - A process for the production of transgenic plants that have a high starch content and yield and a high amylose/amylopectin ratio. The alpha-1,4-glucan phosphorylases (GPs) catalyze the reversible cutting of bonds α-1,4 of the non-reducing ends of homopolysaccharides with at least 5 glucose molecules such as starch, maltodextrin and glycogen, leading to production of glucose-1-phosphate. The GPs in bacteria and animal cells are responsible for the breakdown of glycogen. Although the increase in GP activity leads to a reduction in intracellular levels of glycogen in bacteria and animal cells, this invention discloses the production of plants that have high starch levels and yields and high amylose/amylopectin ratio, as result of the expression of genes coding for GPs. | 11-03-2011 |
Nora Benhabiles, Paris FR
| Patent application number | Description | Published |
|---|---|---|
| 20110053167 | GENE SIGNATURES - The present invention relates generally to a new cluster of correlating molecules in a tissue or at least one cell of a tissue for instance a cell of a blood tissue, preferably such myeloid cells and of identifying the condition of the genes expression said correlating molecules or of the expression levels of said molecules in a method or system for identifying obesity and the risk at obesity-related metabolic diseases such as the obesity associated cardiovascular risk or obesity-related insulin resistance. This system of method provides information on how to modulate the correlating molecules to treat or prevent obesity and to prevent the obesity-related metabolic diseases. | 03-03-2011 |
Nora Dabbous, Suresnes FR
| Patent application number | Description | Published |
|---|---|---|
| 20090172268 | METHOD FOR SECURING A MICROPROCESSOR, CORRESPONDING COMPUTER PROGRAM AND DEVICE - A method is provided for securing a microprocessor containing at least one main program, which operates with at least one memory. The method includes implementing counter-measures, during which additional operations, that are not required for the main program, are implemented so as to modify the consumption of current and/or the processing time of the microprocessor. The method also includes: identification of at least one address or one memory zone of the memory(ies), called critical addresses, and which contain, or which may contain, critical data for said main program; monitoring the addressing ports of the memory(ies), so as to detect the access to the critical address(es); and activation of the step of implementing counter-measures, when an access to the critical address(es) is detected. | 07-02-2009 |
Nora Duhanyan, Nolsy-Le-Grand FR
| Patent application number | Description | Published |
|---|---|---|
| 20090000390 | Method and Apparatus for Measuring the Flow Rates of the Individual Phases of a Multiphase Fluid Mixture - A flow rate measuring method for a multiphase fluid mixture FM flowing into a line LN, the fluid mixture FM comprising at least a first and a second phase, the method comprising the steps of: passing the fluid mixture through a Venturi tube in which the fluid mixture is subjected to a pressure drop, continuously measuring by means of said Venturi tube permanently installed on the line a differential pressure across the Venturi tube ΔP | 01-01-2009 |
Nora Gourdoupi, Patras GR
| Patent application number | Description | Published |
|---|---|---|
| 20080233455 | Proton conductors based on aromatic polyethers and their use as electolytes in high temperature pem fuel cells - Polymer electrolyte membranes with polyethylene oxide and phophonic acid moieties tethered on the main polyether backbone are provided as single phase proton conductors. Preferred polymers can exhibit good mechanical properties, high thermal and oxidative stability. The membrane-electrode assembly (MEA) is also provided. | 09-25-2008 |
| 20080248364 | Proton conducting aromatic polyether type copolymers bearing main and side chain pyridine groups for use in proton exchange membrane fuel cells - New aromatic polyether type copolymers bearing main chain pyridine and side chain pyridine or pyrimidine units, which exhibit good mechanical properties, high thermal and oxidative stability, high doping ability and high conductivity values. The polymers are useful in the preparation and application of MEA on PEMFC type single cells. The polymers are, further, particularly suitable for use in high temperature PEM fuel cells. | 10-09-2008 |
| 20090081487 | Acid-Doped Polyelectrolyte Modified Carbon Nanotubes and their Use in High Temperature PEM Fuel Cell Electrodes - New multifunctional aromatic copolymers bearing pyridine or pyrimidine units either in the main chain or side chain and single wall carbon nanotubes or multi wall carbon nanotubes as side chain pendants have been prepared. These multifunctional materials will combine both high proton and electrical conductivity due to the existence of polar pyridine or pyrimidine groups and carbon nanotubes within the same chemical structure. The prepared multifunctional materials can be used in the catalyst ink of the electrodes in high temperature PEM fuel cells. | 03-26-2009 |
| 20100047660 | DEVELOPMENT AND CHARACTERIZATION OF NOVEL PROTON CONDUCTING AROMATIC POLYETHER TYPE COPOLYMERS BEARING MAIN AND SIDE CHAIN PYRIDINE GROUPS - Featured are novel heterocycle substituted hydroquinones, aromatic copolymers and homopolymers bearing main and side chain polar pyridine units. These polymers exhibit good mechanical properties, high thermal and oxidative stability, high doping ability and high conductivity values. These novel polymers can be used in the preparation and application of MEA on PEMFC type single cells. The combination of the above mentioned properties indicate the potential of the newly prepared materials to be used as electrolytes in high temperature PEM fuel cells. | 02-25-2010 |
Nora Iluri, Weston, MA US
| Patent application number | Description | Published |
|---|---|---|
| 20110208182 | PORTABLE RADIOFREQUENCY HYPERTHERMIA DEVICE WITH FLEXIBLE TREATMENT ELECTRODE FOR ELECTRIC FIELD CAPACITIVE COUPLED ENERGY TRANSFER - The present disclosure relates to a portable radiofrequency (RF) hyperthermia device having flexible applicator treatment electrodes for electric field capacitive coupled energy transfer, the device being useful for increasing the delivery of a systemically delivered drug at a localised target site. The portable RF device is suitable for use by a patient in their own home and the flexible applicator is a flexible, porous, light and easy to manipulate treatment electrode. The inventive device requires no specialist operator to ensure correct usage. | 08-25-2011 |
Nora Kosztolanyi, Beaverton, OR US
| Patent application number | Description | Published |
|---|---|---|
| 20100086475 | Apparatus and Method of Making Transformed Water - The present invention provides an apparatus and method of producing transformed water without contact between the original transformed water and the water to be transformed. This is accomplished by organizing the original transformed water into a geometric contained arrangement such that a central cavity is created that substantially surrounds the water that is to be transformed. The water to be transformed is placed into a confined vessel such as a cylindrical container or a pipe inside the central cavity for about sixty seconds. This water then becomes transformed in the same likeness of the molecular clustering of the original transformed water. | 04-08-2010 |
| 20100186287 | Fuel Apparatus and Method - An apparatus and method of enhancing fuel combustion by organizing an amount of transformed water with a high level of stored energy into a geometric arrangement such that a central cavity is created that substantially surrounds a segment of a fuel line leading to a combustion device such as an internal combustion engine. The fuel passes within the space surrounded by the transformed water and becomes imprinted with a molecular clustering as a result of water memory transfer at a lower level of stored energy. This process alter the properties of the fuel allowing it to be utilized with a higher level of efficiency and with lower emissions of pollutants such as hydrocarbons and carbon monoxide. | 07-29-2010 |
Nora Laryea, Saarbruecken DE
| Patent application number | Description | Published |
|---|---|---|
| 20090326146 | Silane coating material and a process to preduce silane coating - The invention relates to a silane coating material and a process to produce silane coating. | 12-31-2009 |
| 20100092686 | METHOD FOR THE PRODUCTION OF A COATING MATERIAL - The invention relates to a method for producing a coating material as well as the use of the coating material. | 04-15-2010 |
| 20110082254 | METHOD FOR THE PRODUCTION OF A HIGHLY ABRASION-RESISTANT VEHICLE PAINT, VEHICLE PAINT, AND THE USE THEREOF - The invention relates to a method for the production of a highly abrasion-resistant vehicle paint, vehicle paint, and the use thereof. | 04-07-2011 |
Nora Luniak, Saarbrucken DE
| Patent application number | Description | Published |
|---|---|---|
| 20100272659 | RECOMBINANT PREPARATION OF SELECTED BROMELAIN FRACTIONS - The present invention pertains in general to Bromelain and particularly to the different active compounds contained in this complex mixture of proteins. The present invention provides recombinant expressed cysteine proteases, which are found in Bromelain. It has been found that the method for expression of the recombinant proteins is superior to the purification from Bromelain itself. | 10-28-2010 |
| 20110200541 | RECOMBINANT PREPARATION OF BROMELAIN INHIBITORS AND BROMELAIN INHIBITOR PRECURSOR - The present invention pertains in general to Bromelain and particularly to the active compounds contained in this complex mixture of proteins. The present invention provides recombinant expressed Bromelain inhibitor precursor and Bromelain inhibitors, which are found in Bromelain. It has been found that the recombinant expressed inhibitors have superior effects in terms of treatment of disorders and conditions than Bromelain or its protein fractions from plant extracts. | 08-18-2011 |
Nora Mardirosian, Bellemont, AZ US
| Patent application number | Description | Published |
|---|---|---|
| 20110064781 | NOVEL HEPARIN ENTITIES AND METHODS OF USE - The present invention relates to immobilized biologically active entities that retain a significant biological activity following manipulation. The invention also comprises a medical substrate comprising a heparin entity bound onto a substrate via at least one heparin molecule, wherein said bound heparin entity is heparinase-1 sensitive. | 03-17-2011 |
Nora Tarcic, Modiin IL
| Patent application number | Description | Published |
|---|---|---|
| 20100322900 | Treatment of multiple sclerosis with laquinimod - The subject invention provides for methods of reducing the relapse rate and/or reducing the accumulation of physical disability in a relapsing-remitting multiple sclerosis human patient, the method comprising orally administering to the patient a daily dose of 0.6 mg laquinimod. | 12-23-2010 |
| 20110027219 | Treatment of Crohn's disease with laquinimod - This application provides for a method of treating a subject suffering from Crohn's disease, the method comprising periodically administering to the subject an amount of laquinimod or pharmaceutically acceptable salt thereof effective to treat the subject. This application provides for use of laquinimod in the manufacture of a medicament for treating a subject suffering from Crohn's disease. This application also provides for a pharmaceutical composition comprising laquinimod for use in treating a subject suffering from Crohn's disease. | 02-03-2011 |
| 20110217295 | TREATMENT OF LUPUS ARTHRITIS USING LAQUINIMOD - This invention provides a method of treating a subject afflicted with active lupus arthritis comprising periodically administering to the subject an amount of laquinimod or pharmaceutically acceptable salt thereof effective to treat the subject. This invention also provides laquinimod or pharmaceutically acceptable salt thereof for use in treating a subject afflicted with active lupus arthritis. This invention further provides a pharmaceutical composition comprising an amount of laquinimod or pharmaceutically acceptable salt thereof for use in treating a subject afflicted with lupus arthritis. | 09-08-2011 |
| 20110218179 | TREATMENT OF LUPUS NEPHRITIS USING LAQUINIMOD - This invention provides a method of treating a subject afflicted with active lupus nephritis comprising periodically administering to the subject an amount of laquinimod or pharmaceutically acceptable salt thereof effective to treat the subject. This invention also provides laquinimod or pharmaceutically acceptable salt thereof for use in treating a subject afflicted with active lupus nephritis. This invention further provides a pharmaceutical composition comprising an amount of laquinimod or pharmaceutically acceptable salt thereof for use in treating a subject afflicted with active lupus nephritis. | 09-08-2011 |
| 20110218203 | TREATMENT OF RHEUMATOID ARTHRITIS WITH A COMBINATION OF LAQUINIMOD AND METHOTREXATE - This invention provides a method of treating a subject afflicted with rheumatoid arthritis comprising periodically administering to the subject an amount of laquinimod or pharmaceutically acceptable salt thereof and an amount of methotrexate, wherein the amounts when taken together are effective to treat the subject. This invention also provides laquinimod or pharmaceutically acceptable salt thereof for use in combination with methotrexate in treating a subject afflicted with rheumatoid arthritis. This invention also provides a pharmaceutical composition comprising an amount of laquinimod or pharmaceutically acceptable salt thereof and an amount of methotrexate for use in treating a subject afflicted with rheumatoid arthritis. | 09-08-2011 |
Nora Torres-Nagel, Habach DE
| Patent application number | Description | Published |
|---|---|---|
| 20110143372 | ANTIBODIES AGAINST HUMAN EPO RECEPTOR - An antibody binding to human EPO receptor, characterized in specifically binding EPO receptor fragment LDKWLLPRNPPSEDLPGPGGSVDIV (SEQ ID NO:1), CSSALASKPSPEGASAASFEY (SEQ ID NO:2), or GGLSDGPYSNPYENSLIPAAEP (SEQ ID NO:3) is useful for the analysis of EPO receptor in human tissue. | 06-16-2011 |
| 20110165592 | ANTIBODIES AGAINST HUMAN EPO RECEPTOR - An antibody binding to human EPO receptor, characterized in specifically binding EPO receptor fragment LDKWLLPRNPPSEDLPGPGGSVDIV (SEQ ID NO:1), CSSALASKPSPEGASAASFEY (SEQ ID NO:2), or GGLSDGPYSNPYENSLIPAAEP (SEQ ID NO:3) is useful for the analysis of EPO receptor in human tissue. | 07-07-2011 |
Nora Ventosa Rul, Bellaterra ES
| Patent application number | Description | Published |
|---|---|---|
| 20120004308 | METHOD FOR OBTAINING SOLID MICRO- OR NANOPARTICLES - The invention provides a novel method for obtaining solid micro- or nanoparticles with a homogeneous structure. A method is provided for obtaining solid micro- or nanoparticles with a homogeneous structure having a particle size of less than 10 μm where the processed solid compound has the natural, crystalline, amorphous, polymorphic and other features associated with the starting compound. In accordance with the invention a method which also makes it possible to obtain solid micro- or nanoparticles with a substantially spheroidal morphology is provided. | 01-05-2012 |